It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […] …read more […]
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […] …read more […]
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small cap stocks that big investment banks don’t follow. Because of their pay structures, they have strong incentives to do the research necessary […] …read more […]
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […] …read more […]
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […] …read more […]
Just because a business does not make any money, does not mean that the stock will go down. For example, although… …read more […]
The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […] …read more […]
Does Trinity Industries, Inc. (NYSE:TRN) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on satellite photos and other research activities, so it is no wonder why they tend […] …read more […]
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons. Nevertheless, the data show elite investors’ consensus picks have done well on average over the long-term. The top 20 stocks among hedge funds beat the S&P […] …read more […]
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the trade war with China, many smart money investors kept their cautious approach regarding the current bull run in the second quarter and hedging or reducing many of […] …read more […]
Cystic fibrosis patients in England will have access to life-extending drugs after the state-funded health service said it had agreed a pricing deal with manufacturer Vertex Pharmaceuticals. England’s National Health Service (NHS) has been negotiating with Vertex for years about supplying Orkambi, a combination drug that improves lung function. The U.S. company had wanted to charge around 100,000 pounds ($129,000) a year for a course of Orkambi, according to reports. …read more […]
Do you want to build your wealth, but don’t know how to begin?
Wealth creation can seem like a tall order. When it’s hard enough to pay the bills, growing your nest egg can feel daunting. But plenty of people build their fortunes from humble beginnings.
Take John D. Rockefeller for example.
He got his first job as an assistant bookkeeper making only $16 a month. Today he is recognized as the most successful business tycoon in American history. You might not become the next Rockefeller, but you can take the right steps to build your wealth. You just need the right plan, …read more […]
Tesla shocked Wall Street with its earnings report yesterday, revealing that the company has returned to profitability. Yahoo Finance’s Brian Sozzi and Alexis Christoforous break down the quarter with Garrett Nelson of CFRA. …read more […]
When you buy shares in a company, it’s worth keeping in mind the possibility that it could fail, and you could lose… …read more […]
Cystic fibrosis patients in England will have access to life-extending drugs after the state-funded health service said it had agreed a pricing deal with manufacturer Vertex Pharmaceuticals. England’s National Health Service (NHS) has been negotiating with Vertex for years about supplying Orkambi, a combination drug that improves lung function. The U.S. company had wanted to charge around 100,000 pounds ($129,000) a year for a course of Orkambi, according to reports. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
